vimarsana.com

Page 2 - Vishal Kumar Gupta News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bagzone Lifestyles raises $9 million from First Bridge India Growth Fund

Bagzone Lifestyles raises $9 million from First Bridge India Growth Fund
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Lavie raises $9 million investment

Fashion accessories brand Lavie, owned by Bagzone Lifestyles Pvt. Ltd., has secured $9 million in funding from First Bridge India Growth Fund. The investment will be used to establish a manufacturing facility capable of producing 200,000 bags per month and to open 300 exclusive brand outlets. Lavie plans to expand its offline presence in tier 1 and tier 2 cities, aiming to increase its sales from Rs 500 crores in FY23 to Rs 700-750 crores in FY24.

BHU SCIENTISTS CARRY OUT PATHBREAKING STUDY IN T CELL LYMPHOMA (A TYPE OF IMMUNE CELL CANCER) | India Education | Latest Education News | Global Educational News

BHU SCIENTISTS CARRY OUT PATHBREAKING STUDY IN T CELL LYMPHOMA (A TYPE OF IMMUNE CELL CANCER) | India Education | Latest Education News | Global Educational News
indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.

BHU SCIENTISTS CARRY OUT PATHBREAKING STUDY IN T CELL LYMPHOMA (A TYPE OF IMMUNE CELL CANCER) | India Education | Latest Education News | Global Educational News

BHU SCIENTISTS CARRY OUT PATHBREAKING STUDY IN T CELL LYMPHOMA (A TYPE OF IMMUNE CELL CANCER) | India Education | Latest Education News | Global Educational News
indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.